Why Obesity Prevalence Alone is not an Accurate Driver for GLP-1 Sales Segmental Analysis The market is segmented by molecule class, route of administration, payer type, use-case framing, and region
GLP-1 Receptor Agonist Use and Risk of Suicide Death
Although GLP-1 drug manufacturers agreed to a $245 net price, a substantial discount off prevailing list prices, savings to plans from a lower price may have been insufficient to offset higher costs associated with an uptake in GLP-1 use for obesity treatment
Phenotypic and functional characterization of synovial fluid-derived fibroblast-like synoviocytes in rheumatoid arthritis
Semaglutide GLP-1 belongs to a category of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, often referred to as incretin mimetics. By imitating the function of GLP-1, a natural hormone in our bodies, Semaglutide GLP-1 plays an important role in controlling blood sugar levels, reducing appetite, and slowing down gastric emptying all of which can contribute to weight loss